SCHEMBL927221

SCHEMBL927221

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCCc2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.52
PSEN1 P49768 2/20 0.41
PSEN2 P49810 2/20 0.41
APH1B Q8WW43 2/20 0.41
NCSTN Q92542 2/20 0.41
APH1A Q96BI3 2/20 0.41
PSENEN Q9NZ42 2/20 0.41
HSD11B1 P28845 1/20 0.41
PLAAT3 P53816 1/20 0.41
PLAAT5 Q96KN8 1/20 0.41
PLAAT2 Q9NWW9 1/20 0.41
PLAAT4 Q9UL19 1/20 0.41
MAPT P10636 3/20 0.41
RORC P51449 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PTGER3 P43115 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926976 0.91 HSD11B1 (0.46) EPHX2PSEN1PSEN2APH1BNCSTN
SCHEMBL928733 0.88 PSEN1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926724 0.87 PSEN1 (0.46) EPHX2PSEN1PSEN2APH1BNCSTN
SCHEMBL926071 0.86 HSD11B1 (0.46) EPHX2PSEN1PSEN2APH1BNCSTN
SCHEMBL926670 0.86 BDKRB1 (0.44) EPHX2PSEN1PSEN2APH1BNCSTN
SCHEMBL926737 0.85 LMNA (0.46) HSD11B1MAPTRORCSMN1; SMN2ALDH1A1
SCHEMBL927527 0.85 FKBP1A (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL926180 0.84 LMNA (0.48) HSD11B1MAPTRORCSMN1; SMN2ALDH1A1
SCHEMBL926338 0.84 FKBP1A (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL928273 0.83 MAPT (0.49) MAPTRORCMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD EPHX2 3088/4885PSEN1 281/4885PSEN2 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.